Aptitude Health Launches Real-World Evidence Registry Program and Research Network to Enhance Oncology Treatment Outcomes in the Community Setting
Aptitude Health, a global leader in evidence-based oncology and hematology insights, announces the launch of its new real-world evidence (RWE) registry platform and research network, iPROPEL (Precision Research in Oncology through Patient Engagement Longitudinally). This comprehensive research... - December 17, 2024
Aptitude Health Acquires Athena Meetings & Events, Organizer of the Annual UK Oncology Forum, to Strengthen Global Reach
Aptitude Health, a global leader in evidence-based oncology and hematology insights, announces the acquisition of Athena Meetings & Events, a global meetings and events company with over 25 years of experience in the pharmaceutical and healthcare sectors. This strategic acquisition will enable... - November 01, 2024
Aptitude Health Expands European Presence with Acquisition of UK-Based Bamboo Medical Communications Ltd
Aptitude Health, the global market leader in evidence-based solutions for life science companies, announces its successful acquisition of Bamboo Medical Communications Ltd, a prominent UK-based agency. This strategic acquisition strengthens Aptitude Health's commitment to the European marketplace... - August 09, 2023
Aptitude Health Appoints Jez Moulding as CEO
Jez Moulding appointed as CEO of Aptitude Health, a global market leader in evidence-based solutions for life science companies. - January 20, 2023
Aptitude Health Acquires TME BCN
Aptitude Health, a portfolio company of Linden Capital Partners, announced today that it has acquired Targeted Medical Education (TME and TME Research) and their Breast Care Network (BCN) to further strengthen Aptitude Health’s organization and mission to improve health outcomes for cancer patients. - August 11, 2022
Aptitude Health Announces an Organizational Redesign to Better Deliver to Life Sciences Companies the Oncology and Hematology Insights They Need Most
Transformation of business structure and leadership team; Axess Oncology and TRM Oncology rebrand to Aptitude Health; All client accounts and services merge into one new operating company; New solutions improve collaboration between life science partners and clinicians to positively impact patient outcomes - November 09, 2018
prIME Oncology Awarded ACCME Accreditation with Commendation
Accredited evidence-based education bridges gap between oncology innovations and integration into clinical practice. Oncologists and hematologists rely on accredited continuing medical education (CME) as an important support system to assist in improving their clinical practice and care of... - March 30, 2017